AHA 2017

Latest AHA 2017

AHA 2017 Wrap-Up from a Pacific Rim Perspective

By
Medhat

Continued vs Interrupted NOAC at the time of Device Surgery

By
Medhat

Does High-Intensity Pitavastatin Therapy Improve Clinical Outcomes?

By
Medhat

Evolocumab and Outcomes in Patients with PAD

By
Medhat

BP Measurement in the SBP Intervention Trial (SPRINT)

By
Medhat

Exenatide in Type 2 DM and CVD: Insights from EXSCEL Trial

By
Medhat

Residual Inflammatory Risk and Residual Cholesterol Risk: CANTOS Trial

By
Medhat

Bariatric Surgery in Obese Patients with HTN

By
Medhat

Outcomes of Primary Angioplasty and treatment with Prasugrel vs Ticagrelor

By
Medhat

TRICS III – Transfusion Triggers in Cardiac Surgery

By
Medhat

Role of Evidence-Based Treatments in NSTEMI Outcome

By
Medhat

STEMI ACCELERATOR-2 – Regional STEMI Systems of Care

By
Medhat

Improvement of Outcomes for CV Emergencies in the US

By
Medhat

Temporary Neurotoxin Treatment to Prevent Postop AFib

By
Medhat

GM-CSF with and without Supervised Exercise in PAD

By
Medhat

Allogeneic Heart Stem Cells and Myocardial Regeneration

By
Medhat

AHA 2017 Wrap-Up in Portuguese

By
Medhat

AHA 2017 Wrap-Up in Hebrew

By
Medhat

AHA 2017 Wrap-Up from a Pacific Rim Perspective

By
Medhat

AHA 2017 Wrap-Up from the Perspective of the Netherlands

By
Medhat